Woman holding her stomach.

September 16

Patients with inflammatory bowel disease (IBD) who received the COVID-19 vaccine from Johnson & Johnson produced significantly lower levels of antibodies against the SARS-CoV-2 virus than those who received the Pfizer-BioNTech or Moderna vaccines, according to a study led by Cedars-Sinai.

X-ray of chest.

September 16

Cedars-Sinai investigators have made significant progress in identifying the mechanisms behind idiopathic pulmonary fibrosis, a deadly disease that scars the lungs and impairs breathing. The findings appeared in a study published this summer in the journal Science Advances.

Have Questions or Need Help?

Contact us if you have questions or wish to learn more about research at Cedars-Sinai.